Assessment of the quality of life in patients with exogenous allergic alveolitis

To date, over 200 different allergens are isolated, prolonged inhalation of which leads to the development of immune inflammation in the lungs, known as hypersensitive pneumonitis or exogenous allergic alveolitis. The same group usually includes alveolitis caused by taking medications and dietary supplements, the method of delivery and the nature of the impact of which on the pulmonary structures can lead to the development of both allergic and cytotoxic reactions. At the same time, timely recognition and early diagnosis of EA of various genesis, the establishment of the nosological form of the disease are very important, since they allow not only to eliminate the impact, prevent the progression of the disease, but also to choose the most adequate, more effective treatment regimen, expand the use of pathogenetic methods of influencing various links of the inflammatory process. Among the IZL, the diagnosis of exogenous alveolitis (EA) seems to be one of the most difficult, which is recognized by almost all leading experts. According to these authors, diagnostic errors of the disease reach 70%, which makes it difficult to detect it in a timely manner, leads to early disability of patients due to progressive diffuse pneumosclerosis of the respiratory department.